Cargando…

Proliferative diabetic retinopathy transcriptomes reveal angiogenesis, anti-angiogenic therapy escape mechanisms, fibrosis and lymphatic involvement

Proliferative diabetic retinopathy (PDR) is a sight-threatening diabetic complication in urgent need of new therapies. In this study we identify potential molecular mechanisms and target candidates in the pathogenesis of PDR fibrovascular tissue formation. We performed mRNA sequencing of RNA isolate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Korhonen, Ani, Gucciardo, Erika, Lehti, Kaisa, Loukovaara, Sirpa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8458546/ https://www.ncbi.nlm.nih.gov/pubmed/34552123 http://dx.doi.org/10.1038/s41598-021-97970-5

Ejemplares similares

Lymphatic Vascular Structures: A New Aspect in Proliferative Diabetic Retinopathy
por: Gucciardo, Erika, et al.
Publicado: (2018)

A Case of Abnormal Lymphatic-Like Differentiation and Endothelial Progenitor Cell Activation in Neovascularization Associated with Hemi-Retinal Vein Occlusion
por: Loukovaara, Sirpa, et al.
Publicado: (2015)

Soluble and membrane-bound adenylate kinase and nucleotidases augment ATP-mediated inflammation in diabetic retinopathy eyes with vitreous hemorrhage
por: Zeiner, Julian, et al.
Publicado: (2019)

Elevated Levels of Plasma IgA Autoantibodies against Oxidized LDL Found in Proliferative Diabetic Retinopathy but Not in Nonproliferative Retinopathy
por: Vavuli, Satu, et al.
Publicado: (2016)

EphA2 bears plasticity to tumor invasion
por: Sugiyama, Nami, et al.
Publicado: (2013)

Proactive for invasion: Reuse of matrix metalloproteinase for structural memory
por: Gucciardo, Erika, et al.
Publicado: (2016)

Therapeutic Interventions against Inflammatory and Angiogenic Mediators in Proliferative Diabetic Retinopathy
por: Gologorsky, Daniel, et al.
Publicado: (2012)

Angiogenic and Vasculogenic Factors in the Vitreous from Patients with Proliferative Diabetic Retinopathy
por: Abu El-Asrar, Ahmed M., et al.
Publicado: (2013)

Limited Hyperoxia-Induced Proliferative Retinopathy (LHIPR) as a Model of Retinal Fibrosis, Angiogenesis, and Inflammation
por: Corano Scheri, Katia, et al.
Publicado: (2023)

Angiogenic Potential of Vitreous from Proliferative Diabetic Retinopathy and Eales' Disease Patients
por: Murugeswari, Ponnalagu, et al.
Publicado: (2014)

Matrix metalloproteinase-14 is a biomarker of angiogenic activity in proliferative diabetic retinopathy
por: Abu El-Asrar, Ahmed M., et al.
Publicado: (2018)

Expression of the angiogenic mediator, angiopoietin-like 4, in the eyes of patients with proliferative sickle retinopathy
por: Jee, Kathleen, et al.
Publicado: (2017)

Targeting proliferative retinopathy: Arginase 1 limits vitreoretinal neovascularization and promotes angiogenic repair
por: Fouda, Abdelrahman Y., et al.
Publicado: (2022)

Periostin and tenascin-C interaction promotes angiogenesis in ischemic proliferative retinopathy
por: Kubo, Yuki, et al.
Publicado: (2020)

Correlations Between Different Angiogenic and Inflammatory Factors in Vitreous Fluid of Eyes With Proliferative Diabetic Retinopathy
por: Wu, Guanrong, et al.
Publicado: (2021)

Statins for the prevention of proliferative vitreoretinopathy: cellular responses in cultured cells and clinical statin concentrations in the vitreous
por: Mysore, Yashavanthi, et al.
Publicado: (2021)

Tenascin-C promotes angiogenesis in fibrovascular membranes in eyes with proliferative diabetic retinopathy
por: Kobayashi, Yoshiyuki, et al.
Publicado: (2016)

Endothelin-1 is associated with fibrosis in proliferative diabetic retinopathy membranes
por: Chang, William, et al.
Publicado: (2018)

Author Correction: Statins for the prevention of proliferative vitreoretinopathy: cellular responses in cultured cells and clinical statin concentrations in the vitreous
por: Mysore, Yashavanthi, et al.
Publicado: (2021)

Oxidative Stress, Inflammatory, Angiogenic, and Apoptotic molecules in Proliferative Diabetic Retinopathy and Diabetic Macular Edema Patients
por: Andrés-Blasco, Irene, et al.
Publicado: (2023)

The Role of Angiogenesis in the Development of Proliferative Diabetic Retinopathy: Impact of Intravitreal Anti-VEGF Treatment
por: Tremolada, Gemma, et al.
Publicado: (2012)

S100A4 is upregulated in proliferative diabetic retinopathy and correlates with markers of angiogenesis and fibrogenesis
por: Abu El-Asrar, Ahmed M., et al.
Publicado: (2014)

Receptor-associated prorenin system contributes to development of inflammation and angiogenesis in proliferative diabetic retinopathy
por: Kanda, Atsuhiro, et al.
Publicado: (2016)

Axl Is Essential for in-vitro Angiogenesis Induced by Vitreous From Patients With Proliferative Diabetic Retinopathy
por: Wu, Wenyi, et al.
Publicado: (2021)

Vitreous inflammatory and angiogenic factors on patients with proliferative diabetic retinopathy or diabetic macular edema: the role of Lipocalin2
por: Batsos, Georgios, et al.
Publicado: (2022)

Erratum: Axl Is Essential for in-vitro Angiogenesis Induced by Vitreous From Patients With Proliferative Diabetic Retinopathy
por: Frontiers Production Office,
Publicado: (2022)

EphA2 cleavage by MT1-MMP triggers single cancer cell invasion via homotypic cell repulsion
por: Sugiyama, Nami, et al.
Publicado: (2013)

High-Mobility Group Box-1 and Endothelial Cell Angiogenic Markers in the Vitreous from Patients with Proliferative Diabetic Retinopathy
por: Abu El-Asrar, Ahmed M., et al.
Publicado: (2012)

Angiopoietin-like 4 is a potent angiogenic factor and a novel therapeutic target for patients with proliferative diabetic retinopathy
por: Babapoor-Farrokhran, Savalan, et al.
Publicado: (2015)

Actin-associated protein palladin promotes tumor cell invasion by linking extracellular matrix degradation to cell cytoskeleton
por: von Nandelstadh, Pernilla, et al.
Publicado: (2014)

Heritability of Proliferative Diabetic Retinopathy
por: Hietala, Kustaa, et al.
Publicado: (2008)

Proliferative diabetic retinopathy in acromegaly
por: Malhotra, Chintan
Publicado: (2010)

Novel therapies for proliferative retinopathies
por: Martinez-Alejo, Juan Manuel, et al.
Publicado: (2022)

CD40 Ligand–CD40 Interaction Is an Intermediary between Inflammation and Angiogenesis in Proliferative Diabetic Retinopathy
por: Abu El-Asrar, Ahmed M., et al.
Publicado: (2023)

Single-cell transcriptome analyses reveal microglia types associated with proliferative retinopathy
por: Liu, Zhiping, et al.
Publicado: (2022)

Curcumin attenuates angiogenesis in liver fibrosis and inhibits angiogenic properties of hepatic stellate cells
por: Zhang, Feng, et al.
Publicado: (2014)

Proliferative and inflammatory factors in the vitreous of patients with proliferative diabetic retinopathy
por: Chernykh, VV, et al.
Publicado: (2015)

Repair of primary RRD – comparing pars plana vitrectomy procedure with combined phacovitrectomy with standard foldable intraocular lens implantation
por: Loukovaara, Sirpa, et al.
Publicado: (2018)

Statin medication in patients with epiretinal membrane is associated with low intravitreal EPO, TGF-beta-1, and VEGF levels
por: Tuuminen, Raimo, et al.
Publicado: (2016)

Association between NSAID and Statin Therapy and the Incidence of Intravitreal Anti-vascular Endothelial Growth Factor Injections and Nd:YAG Laser Treatment after Cataract Surgery in Finland
por: Loukovaara, Sirpa, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6ao5f0t81q21gi8n4o4fpon07u